Interestingly, higher GR expression was observed on immune cells (T-cells, B-cells and myeloid cells) compared to stromal or cancer cells (p < 0.001) (GSE75688) (Figure 2A), with the highest GR expression on CD8+ T-cells compared to other immune cell subsets including regulatory T-cells (T-regs), CD4+ T-cells, neutrophils, monocytes, dendritic cells, mast cells, and macrophages (p < 0.001) (GSE114725) (Figure 2B). The gene discussed is NR3C1; the disease is cancer.